{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T04:33:16Z","timestamp":1686976396498},"posted":{"date-parts":[[2023,6,16]]},"group-title":"In Review","reference-count":25,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,6,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p>Reverse transcriptase inhibitors (RTIs) are currently broadly prescribed for the treatment of HIV infection but are also thought to prevent Alzheimer\u2019s Disease (AD) progression by protecting against amyloidosis. Our study evaluates the hypothesis that reverse transcriptase inhibitors protect against Alzheimer-type brain amyloidogenesis in the context of HIV infection. We compiled a case series of participants from a prospective study of the neurological consequences of HIV infection at the HIV Neurobehavioral Research Program (HNRP) who had serial neuropsychological and neurological assessments and were on RTIs. Two participants had gross and microscopic examination and immunohistochemistry of the brain at autopsy; one was assessed clinically for Alzheimer\u2019s Disease by cerebrospinal fluid (CSF) analysis of phosphorylated-Tau, Total-Tau and A\u03b242. Additionally, a larger cohort of autopsied individuals was evaluated for presence of amyloid plaques, Tau, and related pathologies. Three older, virally suppressed individuals with HIV who had long-term treatment with RTIs were included in analyses. Two cases demonstrated substantial cerebral amyloid deposition at autopsy. The third case met clinical criteria for AD based on a typical clinical course and CSF biomarker profile. In the larger cohort of autopsied individuals, the prevalence of cerebral amyloidosis among people with HIV (PWH) was greater for those on RTIs. Our study showed that long-term RTI therapy did not protect against Alzheimer-type brain amyloidogenesis in the context of HIV infection in these patients. Given the known toxicities of RTIs, it is premature to recommend them to individuals at risk or with Alzheimer\u2019s disease who do not have HIV infection.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3040756\/v1","type":"posted-content","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T18:24:34Z","timestamp":1686939874000},"source":"Crossref","is-referenced-by-count":0,"title":["Alzheimer-type cerebral amyloidosis in the context of HIV infection: implications for a proposed new treatment approach"],"prefix":"10.21203","author":[{"given":"Ronald J.","family":"Ellis","sequence":"first","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibangi","family":"Pal","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian L.","family":"Achim","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Sundermann","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Moore","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virawudh","family":"Soontornniyomkij","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Feldman","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","article-title":"Increased accumulation of intraneuronal amyloid beta in HIV-infected patients","volume":"4","author":"Achim CL","year":"2009","unstructured":"Achim CL, Adame A, Dumaop W, Everall IP, Masliah E, Neurobehavioral Research C (2009) Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 4:190\u2013199","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/iub.1106","article-title":"Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier","volume":"65","author":"Andras IE","year":"2013","unstructured":"Andras IE, Toborek M (2013) Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier. IUBMB Life 65:43\u201349","journal-title":"IUBMB Life"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/15284336.2016.1176305","article-title":"A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitors","volume":"17","author":"Barber TJ","year":"2016","unstructured":"Barber TJ, Moyle G, Hill A, Jagjit Singh G, Scourfield A, Yapa HM, Waters L, Asboe D, Boffito M, Nelson M (2016) A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitors. HIV Clin Trials 17:123\u2013130","journal-title":"HIV Clin Trials"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11481-019-09858-x","article-title":"Cerebral Vascular Toxicity of Antiretroviral Therapy","volume":"16","author":"Bertrand L","year":"2021","unstructured":"Bertrand L, Velichkovska M, Toborek M (2021) Cerebral Vascular Toxicity of Antiretroviral Therapy. J Neuroimmune Pharmacol 16:74\u201389","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp.65.1.29","article-title":"Prevalence of Alzheimer plaques in AIDS","volume":"65","author":"Esiri MM","year":"1998","unstructured":"Esiri MM, Biddolph SC, Morris CS (1998) Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 65:29\u201333","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12012-016-9397-4","article-title":"Effect of the Anti-retroviral Drugs Efavirenz, Tenofovir and Emtricitabine on Endothelial Cell Function: Role of PARP","volume":"17","author":"Faltz M","year":"2017","unstructured":"Faltz M, Bergin H, Pilavachi E, Grimwade G, Mabley JG (2017) Effect of the Anti-retroviral Drugs Efavirenz, Tenofovir and Emtricitabine on Endothelial Cell Function: Role of PARP. Cardiovasc Toxicol 17:393\u2013404","journal-title":"Cardiovasc Toxicol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"17158","DOI":"10.1038\/s41598-019-53466-x","article-title":"Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice","volume":"9","author":"Fields JA","year":"2019","unstructured":"Fields JA, Swinton MK, Carson A, Soontornniyomkij B, Lindsay C, Han MM, Frizzi K, Sambhwani S, Murphy A, Achim CL, Ellis RJ, Calcutt NA (2019) Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice. Sci Rep 9:17158","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/13550280490279816","article-title":"Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation","volume":"10","author":"Gelman BB","year":"2004","unstructured":"Gelman BB, Schuenke K (2004) Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation. J Neurovirol 10:98\u2013108","journal-title":"J Neurovirol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","article-title":"Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients","volume":"19","author":"Green DA","year":"2005","unstructured":"Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19:407\u2013411","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbalip.2010.05.003","article-title":"Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis","volume":"1801","author":"Haughey NJ","year":"2010","unstructured":"Haughey NJ, Bandaru VV, Bae M, Mattson MP (2010) Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. Biochim Biophys Acta 1801:878\u2013886","journal-title":"Biochim Biophys Acta"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/978-1-4939-7101-5_222","volume-title":"Encyclopedia of AIDS","author":"Heaton RK","year":"2018","unstructured":"Heaton RK, Iudicello JE (2018) Neuropsychological Testing in HIV-Infected Individuals. In: Hope TJ, Richman DD, Stevenson M (eds) Encyclopedia of AIDS. Springer New York, New York, NY, pp 1494\u20131505"},{"key":"ref12","first-page":"175","article-title":"Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS)","volume":"38","author":"Izycka-Swieszewska E","year":"2000","unstructured":"Izycka-Swieszewska E, Zoltowska A, Rzepko R, Gross M, Borowska-Lehman J (2000) Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS). Folia Neuropathol 38:175\u2013182","journal-title":"Folia Neuropathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/em.20223","article-title":"A brief overview of mechanisms of mitochondrial toxicity from NRTIs","volume":"48","author":"Kohler JJ","year":"2007","unstructured":"Kohler JJ, Lewis W (2007) A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen 48:166\u2013172","journal-title":"Environ Mol Mutagen"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-018-0718-6","article-title":"Somatic APP gene recombination in Alzheimer's disease and normal neurons","volume":"563","author":"Lee MH","year":"2018","unstructured":"Lee MH, Siddoway B, Kaeser GE, Segota I, Rivera R, Romanow WJ, Liu CS, Park C, Kennedy G, Long T, Chun J (2018) Somatic APP gene recombination in Alzheimer's disease and normal neurons. Nature 563:639\u2013645","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"Lewis W","year":"2003","unstructured":"Lewis W, Day BJ, Copeland WC (2003) Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2:812\u2013822","journal-title":"Nat Rev Drug Discov"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann GM","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263\u2013269","journal-title":"Alzheimers Dement"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00002030-200103300-00005","article-title":"Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients","volume":"15","author":"Nebuloni M","year":"2001","unstructured":"Nebuloni M, Pellegrinelli A, Ferri A, Bonetto S, Boldorini R, Vago L, Grassi MP, Costanzi G (2001) Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients. AIDS 15:571\u2013575","journal-title":"AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41419-018-0341-3","article-title":"Organellar stress intersects the astrocyte endoplasmic reticulum, mitochondria and nucleolus in HIV associated neurodegeneration","volume":"9","author":"Nooka S","year":"2018","unstructured":"Nooka S, Ghorpade A (2018) Organellar stress intersects the astrocyte endoplasmic reticulum, mitochondria and nucleolus in HIV associated neurodegeneration. Cell Death Dis 9:317","journal-title":"Cell Death Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","article-title":"Antiretroviral neurotoxicity","volume":"18","author":"Robertson K","year":"2012","unstructured":"Robertson K, Liner J, Meeker RB (2012) Antiretroviral neurotoxicity. J Neurovirol 18:388\u2013399","journal-title":"J Neurovirol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1517\/14740331003627458","article-title":"Renal toxicity associated with tenofovir use","volume":"9","author":"Rodriguez-N\u00f3voa S","year":"2010","unstructured":"Rodriguez-N\u00f3voa S, Alvarez E, Labarga P, Soriano V (2010) Renal toxicity associated with tenofovir use. Exp Opin Drug Saf 9:545\u2013559","journal-title":"Exp Opin Drug Saf"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrneph.2015.75","article-title":"Risk factors: Individual assessment of CKD risk in HIV-positive patients","volume":"11","author":"Scherzer R","year":"2015","unstructured":"Scherzer R, Shlipak MG (2015) Risk factors: Individual assessment of CKD risk in HIV-positive patients. Nat Rev Nephrol 11:392","journal-title":"Nat Rev Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1097\/QAD.0b013e32835a117c","article-title":"Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers","volume":"26","author":"Soontornniyomkij V","year":"2012","unstructured":"Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, Gelman BB, Morgello S, Cherner M, Grant I, Achim CL (2012) Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers. AIDS 26:2327\u20132335","journal-title":"AIDS"},{"key":"ref23","volume-title":"Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders","author":"Sundermann EE","year":"2020","unstructured":"Sundermann EE, Bondi MW, Campbell LM, Gouaux B, Moore RC, Soontornniyomkij V, Moore DJ (2020) Distinguishing amnestic mild cognitive impairment from HIV-associated neurocognitive disorders. J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acs.molpharmaceut.8b01014","article-title":"Targeted Mitochondrial COQ10 Delivery Attenuates Antiretroviral-Drug-Induced Senescence of Neural Progenitor Cells","volume":"16","author":"Velichkovska M","year":"2019","unstructured":"Velichkovska M, Surnar B, Nair M, Dhar S, Toborek M (2019) Targeted Mitochondrial COQ10 Delivery Attenuates Antiretroviral-Drug-Induced Senescence of Neural Progenitor Cells. Mol Pharm 16:724\u2013736","journal-title":"Mol Pharm"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1468-1293.2009.00716.x","article-title":"Tenofovir-associated renal and bone toxicity","volume":"10","author":"Woodward CL","year":"2009","unstructured":"Woodward CL, Hall AM, Williams IG, Madge S, Copas A, Nair D, Edwards SG, Johnson MA, Connolly JO (2009) Tenofovir-associated renal and bone toxicity. HIV Med 10:482\u2013487","journal-title":"HIV Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3040756\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3040756\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T18:24:52Z","timestamp":1686939892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3040756\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":25,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3040756\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,6,16]]},"subtype":"preprint"}}